What Challenges are Faced in Inhibitor Development?
The development of cancer inhibitors faces several challenges. One major hurdle is the development of drug resistance, where cancer cells adapt to overcome the inhibitory effects. Additionally, achieving specificity is crucial; inhibitors must target cancer cells without affecting normal cells to minimize side effects. The complexity of cancer biology and the heterogeneity of tumors also complicate the development process.
